Try our Advanced Search for more refined results
Competition
-
February 13, 2026
Ga. Nursing Board Faces Suit Over Student Placement Policy
The Georgia Board of Nursing is violating federal antitrust law with a "protectionist" policy that prevents online and out-of-state nursing programs from placing their students at Georgia facilities for clinical rotations, an online college told a federal court.
-
February 13, 2026
Zillow, Redfin Say FTC Suit Fails To Show Antitrust Harm
Zillow Group Inc. and Redfin Corp. backed up their attempt to escape a Virginia federal lawsuit from the Federal Trade Commission by arguing that the agency had overlooked the value to both renters and advertisers in a partnership between the companies not to compete for ads.
-
February 13, 2026
MoFo, Paul Hastings Build $4.5B Tri Pointe Homes Sale
Morrison Foerster LLP-advised Sumitomo Forestry Co. Ltd. announced plans Friday to acquire Tri Pointe Homes, advised by Paul Hastings LLP, in a $4.5 billion all-cash deal that will take the U.S. homebuilder private.
-
February 13, 2026
EU Announces Duties Against Korean, Taiwanese Plastics
Imports of a plastic with a wide range of uses from South Korea and Taiwan into the European Union and an amino acid imported from China were hit with antidumping duties Friday, the European Commission announced.
-
February 13, 2026
UK Opens Probe Into Daily Mail Owner's £500M Telegraph Deal
Britain's competition and communications regulators said Friday that they have launched parallel investigations into the proposed £500 million ($680 million) acquisition of Telegraph Media Group by the owner of the Daily Mail newspaper as they respond to instructions from the government.
-
February 12, 2026
FTC Merger Filing Overhaul Thrown Out
The Federal Trade Commission hasn't shown the costs on merging companies outweigh the claimed benefits of dramatically increasing the amount of information that must be provided upfront when giving notice of a transaction, a Texas federal judge said Thursday, throwing out the commission's overhaul of premerger reporting requirements.
-
February 12, 2026
5 Key Flashpoints From Fed's 'Skinny' Account Proposal
The Federal Reserve's push to create "skinny" master accounts that would open up access to U.S. payment rails has become the latest front in long-running turf wars between banks and fintech companies. Here are five of the project's hottest flashpoints attracting controversy.
-
February 12, 2026
State Antitrust Enforcement On The Upswing, Panelists Agree
Speaking at a Silicon Valley antitrust conference hosted Thursday by Baker McKenzie LLP, a senior California antitrust enforcer, an in-house Intel attorney, a University of Southern California law professor, and others agreed that the country is headed into a period of increased activity by state antitrust enforcers.
-
February 12, 2026
12 Questions For FCC Chair Brendan Carr
It's been a "banger" of a year at the Federal Communications Commission, says agency chief Brendan Carr, who took over at the outset of President Donald Trump's second term with the goal of cutting regulations and quickly turning over more spectrum to the private sector.
-
February 12, 2026
HPE Has 'No Grounds' To Hide DOJ Deal Bidders, AGs Say
Democratic attorneys general challenging the controversial Justice Department settlement permitting Hewlett Packard Enterprise's $14 billion purchase of Juniper Networks have urged a California federal judge to let them see who's bidding for assets up for divestiture, arguing the would-be buyers are an integral part of the agreement's viability.
-
February 12, 2026
FTC's PBM Case Paused For More Deal Talks
Federal Trade Commission staffers are discussing potential settlements with OptumRx and Caremark that could end the agency's case accusing the pharmacy benefit managers of inflating insulin prices, following a recent deal with Express Scripts.
-
February 12, 2026
Elon University Says Sportswear Co. Using TM To Sell Clothes
Elon University told a North Carolina federal court that a Washington-based online apparel seller is willfully infringing on its trademarks, some of which are over a century old, and damaging the school by marring its reputation for high-quality apparel.
-
February 12, 2026
Ex-Pharma Exec Fights AGs' Quick Win Bid In Antitrust Case
A former pharmaceutical marketing executive urged a Connecticut federal court to reject summary judgment sought against him by state attorneys general pursuing wider price-fixing litigation against most of the generic drug industry, arguing key cooperating witnesses' questionable credibility makes a trial necessary.
-
February 12, 2026
AI Mapping Co. Accused Of Copying Rival's Maps, Technology
An apartment mapping software company has accused a former potential business partner of copying thousands of its property maps and using them to launch a competing 3D product, alleging in a federal copyright and breach of contract lawsuit that it is losing customers as a result.
-
February 12, 2026
Commerce Examining Mexican Strawberries For Antidumping
The U.S. Department of Commerce on Monday opened an investigation into whether winter strawberries imported from Mexico are being sold at less than fair value, coinciding with a U.S. International Trade Commission investigation into possible harms.
-
February 12, 2026
Colo. Builder Says Ex-Assistant Stole Trade Secrets
The former executive assistant of a high-end Denver homebuilder misappropriated confidential vendor and customer information to pursue a competing business in violation of federal and state trade secrets laws, the construction company told a Colorado federal court.
-
February 12, 2026
ITC Finds Van Trailer Imports Harmed US Production
Imported van-type trailers and their assemblies entering the U.S. from Mexico, Canada and China are harming U.S. producers, the U.S. International Trade Commission said Thursday.
-
February 12, 2026
Regeneron, Samsung Bioepis Settle Eye Med Patent Claims
Regeneron Pharmaceuticals Inc. and Samsung Bioepis Co. Ltd. have told a West Virginia federal court they reached an agreement to end patent infringement claims brought by Regeneron over a biosimilar of its eye medication Eylea.
-
February 12, 2026
Competition Group Of The Year: Wilkinson Stekloff
Wilkinson Stekloff LLP negotiated a crucial settlement for the NCAA while successfully defending it against follow-up cases targeting player eligibility rules and name, image and likeness compensation, earning the firm a spot as one of the 2025 Law360 Competition Groups of the Year.
-
February 12, 2026
DOJ Antitrust Chief Slater Stepping Down
Assistant Attorney General Gail Slater, head of the U.S. Department of Justice's Antitrust Division, said on Thursday she will be leaving her post just shy of a year after being confirmed by the Senate.
-
February 12, 2026
Daily Mail Owner's £500M Telegraph Deal To Be Scrutinized
The government said Thursday that it has referred the £500 million ($681 million) acquisition of Telegraph Media Group by the owner of the Daily Mail newspaper to the competition and communications regulators after raising concerns about media plurality in the U.K.
-
February 12, 2026
FTC Chairman Targets Apple News' 'Left-Wing' Favoritism
Federal Trade Commission Chairman Andrew N. Ferguson escalated his campaign against alleged censorship of conservative viewpoints with a "warning letter" sent directly to Apple CEO Tim Cook citing reports that Apple News favors "left-wing news outlets" and suppresses conservative ones.
-
February 11, 2026
Renters Can't Block RealPage, Equity Residential Subpoenas
A Tennessee federal judge has refused to quash subpoenas issued by property management software company RealPage Inc. and property owner Equity Residential in multidistrict litigation that accuses landlords of using RealPage software to fix rental prices.
-
February 11, 2026
Fed. Circ. Backs $85M Patent Antitrust Verdict Against Ingevity
The Federal Circuit on Wednesday declined to disturb a Delaware jury's $85 million antitrust verdict against Ingevity over it tying patent licenses to purchases of its automobile carbon filtering technology, rejecting the company's arguments that it was entitled to a certain statutory patent misuse defense.
-
February 11, 2026
AGs Warn Cos. Plastic Initiatives May Break Competition Laws
The attorneys general of 10 red states have warned 80 corporations that their purported involvement in organizations aiming to reduce plastic waste might run afoul of antitrust and consumer protection laws, following similar competition-focused actions targeting environmental and diversity groups at the state and federal levels.
Expert Analysis
-
FTC, CoStar Cases Against Zillow May Have Broad Impact
Zillow's partnerships with Redfin and Realtor.com have recently triggered dual fronts of legal scrutiny — an antitrust inquiry from the Federal Trade Commission and a mass copyright infringement suit from CoStar — raising complex questions that reach beyond real estate, says Shubha Ghosh at Syracuse University College of Law.
-
How 2nd Circ. Cannabis Ruling Upends NY Licensing
A recent Second Circuit decision in Variscite NY Four v. New York, holding that New York's extra-priority cannabis licensing preference for applicants with in-state marijuana convictions violates the dormant commerce clause, underscores that state-legal cannabis markets remain subject to the same constitutional constraints as other economic markets, say attorneys at Harris Beach.
-
Parenting Skills That Can Help Lawyers Thrive Professionally
As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.
-
Series
Teaching Trial Advocacy Makes Us Better Lawyers
Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.
-
A Change In Big Pharma Response To FTC Delisting Warnings
While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.
-
9th Circ. Finding That NFTs Are Goods Will Change TM Law
The Ninth Circuit's recent ruling in Yuga Labs v. Ripps establishes that NFTs have real, commercial value under U.S. federal trademark law, a new legal precedent that may significantly influence intellectual property enforcement and marketplace policies regarding digital assets going forward, say attorneys at Wilson Elser.
-
Series
Adapting To Private Practice: From Texas AUSA To BigLaw
As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.
-
Lessons From Liberty Mutual FCPA Declination
Liberty Mutual’s recent Foreign Corrupt Practices Act resolution with the U.S. Department of Justice signals that the Trump administration is once again considering such declinations after an enforcement pause, offering some assurances for companies regarding the benefits of voluntary self-disclosure, say attorneys at Paul Weiss.
-
Advice For 1st-Gen Lawyers Entering The Legal Profession
Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.
-
FTC Focus: When Green Goals And Antitrust Law Collide
A recently concluded Federal Trade Commission investigation has turned an emissions deal involving major U.S. heavy-duty truck manufacturers that was brokered by the California Air Resources Board into a cautionary tale about the potential for environmental agreements to run afoul of competition rules, say attorneys at Proskauer.
-
Structuring Noncompetes In License And Collaboration Deals
As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.
-
Series
Coaching Cheerleading Makes Me A Better Lawyer
At first glance, cheerleading and litigation may seem like worlds apart, but both require precision, adaptability, leadership and the ability to stay composed under pressure — all of which have sharpened how I approach my work in the emotionally complex world of mass torts and personal injury, says Rashanda Bruce at Robins Kaplan.
-
Ruling Puts 11th Circ. At Odds With Bankruptcy Courts
While an Eleventh Circuit majority recently found in BenShot v. 2 Monkey Trading and Lucky Shot USA that corporate debtors, like individuals, face certain exceptions to discharge under a nonconsensual Subchapter V plan, the ruling not only reverses the lower court, but opposes the holdings of many other bankruptcy courts, say attorneys at McDermott.
-
Series
Law School's Missed Lessons: How To Make A Deal
Preparing lawyers for the nuances of a transactional practice is not a strong suit for most law schools, but, in practice, there are six principles that can help young M&A lawyers become seasoned, trusted deal advisers, says Chuck Morton at Venable.
-
Annual Report Shows CFIUS Extending Its Reach In 2024
The recently released 2024 annual report from the Committee on Foreign Investment in the United States reveals record civil penalties and enhanced internal capabilities, illustrating expanding jurisdiction and an increasing appetite for enforcement actions, says Nathan Fisher at StoneTurn.